Industry

Cancer Gene Therapy Market Research 2018-2025: Global Industry Top Players (OncoGenex Pharmaceuticals, Adaptimmune, Merck, Bluebird bio, Inc,GlaxoSmithKline and Shanghai Sunway Biotech)

Cancer Gene Therapy Market Research 2018: Global Industry Demand, Technology, Application, Top Key Players and Forecast 2025

Global Cancer Gene Therapy Market industry valued approximately USD 0.2 billion in 2016 is anticipated to grow with a healthy growth rate of more than 35.1% over the forecast period 2017-2025. The major factors driving the growth are rising need for Cancer Gene Therapy worldwide, increase in prevalence of cancer, increase in geriatric population, increase in funding for R&D activities of cancer gene therapy and favorable government regulations.

The objective of the study is to define market sizes of different segments & countries in previous years and to forecast the values to the next eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry with respect to each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as drivers & restraining factors which will define the future growth of the market.

Looking for More Information on This Market Get Free Sample Report @ http://www.researchformarkets.com/sample/global-cancer-gene-therapy-market-11210

Additionally, it will also incorporate the opportunities available in micro markets for stakeholders to invest, detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

End-User:

  • Diagnostics Centers
  • Hospitals
  • Research Institutes

Therapy:

  • Oncolytic Virotherapy
  • Gene Induced Immunotherapy
  • Gene transfer
  • Others

Regions:

  • North America
  • Asia Pacific
  • Rest of the World

Furthermore, the years considered for the study are as follows:

  • Historical year – 2015
  • Base year – 2016
  • Forecast period – 2017 to 2025

Some of the key manufacturers involved in the market are OncoGenex Pharmaceuticals, Adaptimmune,

Merck, Bluebird bio, Inc,GlaxoSmithKline, Shanghai Sunway Biotech, BioCancell, Celgene, Shenzhen SiBiono GeneTech and SynerGene Therapeutics.Acquisitions and effective mergers are some of the strategies adopted by the key manufacturers. New product launches and focuses on continuous technology innovations are also strategies adopted by the major players. The companies are also trying to dominate the market by investing in research and development.

Target Audience of the Cancer Gene Therapy Market Study

  • Key Consulting Companies & Advisors
  • Large, medium-sized, and small enterprises
  • Venture capitalists
  • Value-Added Resellers (VARs)
  • Third-party knowledge providers
  • Investment bankers
  • Investors
  • Adaptimmune
  • Merck
  • Bluebird bio,Inc
  • GlaxoSmithKline
  • Shanghai Sunway Biotech
  • BioCancell
  • Celgene
  • Shenzhen SiBiono GeneTech
  • SynerGene Therapeutics

The report is available on discount for a limited time only @ http://www.researchformarkets.com/discount/global-cancer-gene-therapy-market-11210

Table of Content

Chapter 1. Research Methodology

1.1. Research Process

1.2. Research Assumption

Chapter 2. Global Cancer Gene Therapy Market Definition & Scope

2.1. Objective of The Study

2.2. Market Definition

2.3. Scope of The Study

2.4. Years Considered for The Study

2.5. Currency Conversion Rates

2.6. Report Limitation

Chapter 3. Executive Summary

3.1. Key Trends

3.2. Global & Segmental Market Estimates & Forecasts, 2015-2025 (USD Billion/Million)

Chapter 4. Global Cancer Gene Therapy Industry Dynamics

4.1. Growth Prospects

4.2. Industry Analysis

4.3. Analyst Recommendation & Conclusion

Chapter 5. Global Cancer Gene Therapy Market by End-User

5.1. Market Snapshot

5.2. Cancer Gene Therapy Market, Sub Segment Analysis

5.2.2. Hospitals

5.2.3. Research Institutes

Chapter 6. Global Cancer Gene Therapy Market by Therapy

6.1. Market Snapshot

6.2. Cancer Gene Therapy Market, Sub Segment Analysis

6.2.1. Oncolytic Virotherapy

6.2.2. Gene Induced Immunotherapy

6.2.3. Gene Transfer

6.2.4. Others

Chapter 7. Global Cancer Gene Therapy Market, Regional Analysis

7.1. Cancer Gene Therapy Market, Regional Market Snapshot (2015-2025)

7.2. North America Cancer Gene Therapy Market Snapshot

7.4. Asia Cancer Gene Therapy Market Snapshot

7.5. Latin America

7.6. Rest of The World Cancer Gene Therapy Market Snapshot

Chapter 8. Competitive Intelligence

8.1. Company Market Share (Subject to Data Availability)

8.2. Top Market Strategies

8.3. Company Profiles

8.3.1. OncoGenex Pharmaceuticals

8.3.2. Adaptimmune

8.3.3. Merck

8.3.4. Bluebird bio,Inc

8.3.5. GlaxoSmithKline

8.3.6. Shanghai Sunway Biotech

8.3.7. BioCancell

8.3.8. Celgene

8.3.9. Shenzhen SiBiono GeneTech

8.3.10. SynerGene Therapeutics

Looking for more insights from this report @ http://www.researchformarkets.com/reports/global-cancer-gene-therapy-market-11210

About Research for Markets:

Research for Markets indulges in detailed and diligent research on different markets, trends and emerging opportunities in the successive direction to cater to your business needs. We have established the pillars of our flourishing institute on the grounds of Credibility and Reliability. RFM delve into the markets across Asia Pacific, North America, South America, Europe, Middle East and Africa.

Our purpose is to serve you, the most customized in-depth Market access data. Our plethora of titles made us one of the most searched market research library across the globe. We work with the most esteemed Publishers around the globe who caters vast industries. We are quick and fragile, when it comes to your various queries, and we ensure our team caters your needs to the best of our abilities, we promise to stay by your side for both pre and post sales servicing, as we believe in long everlasting symbiotic relationship.

Contact:

Mr. A Naidu

Research for Markets

Tel: +44 8000-4182-37 (UK)

Email: alan.naidu@researchformarkets.com